Boston Scientific halted the sales of its second-generation Watchman FLX in Europe because of higher-than-expected embolism rates. The complication resulted in one death that was linked to postoperative infection after the device was percutaneously removed.
Life April 6, 2016
Boston Scientific's Watchman Left Atrial Appendage Closure (LAAC) Device intends to prevent stroke. It is a non-drug substitute for Warfarin.
Life March 16, 2015